Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Ohtsuka S, Shiraishi Y
Acta Neurochir (Wien). 2025; 167(1):49.
PMID: 39969596
PMC: 11839683.
DOI: 10.1007/s00701-025-06465-z.
Yang C, Hassan H, Omar N, Soo T, Shuib Bin Yahaya A, Shi T
Heliyon. 2025; 10(22):e40291.
PMID: 39748993
PMC: 11693897.
DOI: 10.1016/j.heliyon.2024.e40291.
Pfluger I, Rastogi A, Casagranda S, Papageorgakis C, Behnisch R, Liebig P
Eur Radiol. 2024; .
PMID: 39694884
DOI: 10.1007/s00330-024-11197-2.
Cronin A, Liebig P, Detombe S, Duggal N, Bartha R
Sci Rep. 2024; 14(1):25637.
PMID: 39465319
PMC: 11514173.
DOI: 10.1038/s41598-024-75777-4.
Wu J, Huang Q, Shen Y, Guo P, Zhou J, Jiang S
Int J Imaging Syst Technol. 2024; 34(2).
PMID: 39185083
PMC: 11343505.
DOI: 10.1002/ima.23027.
Joint - Space Image Reconstruction and Data Fitting for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging.
Peng Y, Dai Y, Zhang S, Deng J, Jia X
Tomography. 2024; 10(7):1123-1138.
PMID: 39058057
PMC: 11280605.
DOI: 10.3390/tomography10070085.
Intramolecular Hydrogen Bonding Based CEST MRI Contrast Agents As an Emerging Design Strategy: A Mini-Review.
Mohanta Z, Gori S, McMahon M
ACS Omega. 2024; 9(26):27755-27765.
PMID: 38973929
PMC: 11223143.
DOI: 10.1021/acsomega.4c02296.
Utilizing the amide proton transfer technique to characterize diffuse gliomas based on the WHO 2021 classification of CNS tumors.
Filimonova E, Pashkov A, Borisov N, Kalinovsky A, Rzaev J
Neuroradiol J. 2024; 37(4):490-499.
PMID: 38548655
PMC: 11366199.
DOI: 10.1177/19714009241242658.
Advances in spinal cord injury: insights from non-human primates.
Poulen G, Perrin F
Neural Regen Res. 2024; 19(11):2354-2364.
PMID: 38526271
PMC: 11090432.
DOI: 10.4103/NRR.NRR-D-23-01505.
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon.
Tseng C, Zeng K, Mellon E, Soltys S, Ruschin M, Lau A
Neuro Oncol. 2024; 26(12 Suppl 2):S3-S16.
PMID: 38437669
PMC: 10911794.
DOI: 10.1093/neuonc/noad258.
Preclinical Application of CEST MRI to Detect Early and Regional Tumor Response to Local Brain Tumor Treatment.
Park S, Lai J, Han X, Leung V, Xiao P, Huang J
Pharmaceutics. 2024; 16(1).
PMID: 38258112
PMC: 10820766.
DOI: 10.3390/pharmaceutics16010101.
Spatiotemporal Dynamics of Neuroinflammation Relate to Behavioral Recovery in Rats with Spinal Cord Injury.
Mu C, Reed J, Wang F, Tantawy M, Gore J, Chen L
Mol Imaging Biol. 2023; 26(2):240-252.
PMID: 38151582
DOI: 10.1007/s11307-023-01875-w.
Added-value of 3D amide proton transfer MRI in assessing prognostic factors of cervical cancer: a comparative study with multiple model diffusion-weighted imaging.
Li S, Liu J, Zhang Z, Wang W, Lu H, Lin L
Quant Imaging Med Surg. 2023; 13(12):8157-8172.
PMID: 38106243
PMC: 10722001.
DOI: 10.21037/qims-23-324.
Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of C-methionine positron emission tomography.
Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Shiraishi Y, Taniwaki M
Neurosurg Rev. 2023; 46(1):294.
PMID: 37925381
DOI: 10.1007/s10143-023-02202-1.
Contrasting Properties of Polymeric Nanocarriers for MRI-Guided Drug Delivery.
Lopuszynska N, Weglarz W
Nanomaterials (Basel). 2023; 13(15).
PMID: 37570481
PMC: 10420849.
DOI: 10.3390/nano13152163.
3D CEST MRI with an unevenly segmented RF irradiation scheme: A feasibility study in brain tumor imaging.
Kim H, Park S, Hu R, Hoang K, Sun P
Magn Reson Med. 2023; 90(6):2400-2410.
PMID: 37526017
PMC: 10586718.
DOI: 10.1002/mrm.29810.
Biogenic Imaging Contrast Agents.
Dan Q, Jiang X, Wang R, Dai Z, Sun D
Adv Sci (Weinh). 2023; 10(25):e2207090.
PMID: 37401173
PMC: 10477908.
DOI: 10.1002/advs.202207090.
Longitudinal multiparametric MRI of traumatic spinal cord injury in animal models.
Chen L, Wang F, Mishra A, Yang P, Sengupta A, Reed J
Magn Reson Imaging. 2023; 102:184-200.
PMID: 37343904
PMC: 10528214.
DOI: 10.1016/j.mri.2023.06.007.
Amide Proton Transfer-Chemical Exchange Saturation Transfer Imaging of Intracranial Brain Tumors and Tumor-like Lesions: Our Experience and a Review.
Koike H, Morikawa M, Ishimaru H, Ideguchi R, Uetani M, Miyoshi M
Diagnostics (Basel). 2023; 13(5).
PMID: 36900058
PMC: 10000843.
DOI: 10.3390/diagnostics13050914.
Predicting a Favorable (mRS 0-2) or Unfavorable (mRS 3-6) Stroke Outcome by Arterial Spin Labeling and Amide Proton Transfer Imaging in Post-Thrombolysis Stroke Patients.
He Q, Li G, Jiang M, Zhou Q, Gao Y, Yan J
J Pers Med. 2023; 13(2).
PMID: 36836482
PMC: 9962289.
DOI: 10.3390/jpm13020248.